In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Selected Start-Ups (01/01)

Executive Summary

In Vivo summarizes the technologies of several recently founded companies: Advanced BioChem Inc. provides contract protein biochemistry, immunoassay and proteomics services to companies developing pharmaceuticals and medical diagnostics tests. Arradial Inc. aims to accelerate the discovery and validation of therapeutic compounds with a personal desktop laboratory microarray screening system created jointly by Boston University and Alexion Pharmaceuticals Inc. Spun out of Evotec BioSystems AG, Direvo Biotech AG will use its directed evolution platform to optimize biomolecules for industrial applications, as well as to develop proteins for novel therapeutics. Evacyte Microarray Diagnostics Corp.'s new cancer detection device, the Optical Stretcher, uses laser beams to stretch individual cells, enabling doctors to extract very small samples to determine if cancer cells are present. Palumed SA is developing small molecule drugs for the treatment of malaria and other infectious diseases. Using technology developed by its founders at the University of Texas' MD Anderson Cancer Center and in collaboration with Tripos Inc., Signase Inc. will develop small-molecule inhibitors of protein tyrosine kinases to enhance the effectiveness of chemotherapy directed at various types of solid tumors.
Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV001536

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel